Trident Clinical Research News

06 June 2011

Trident to attend BIO 2011 in Washington on 28 June

Karen West, BD Director will be at the Australia Pavillion on Tuesday 28 June 2011.

02 June 2011

Trident Clinical Research acquired by INC Research

Please click here for the media release.

01 May 2011

Trident to attend ARCS Scientific Congress in Sydney on 26 to 27 May

Please drop by and visit Karen and Stella at Booth No. 49.

Also, Diane Robinson, Tridents QA Director will be presenting at the congress the session “Can’t see the Forest for the Trees?  Site Monitoring with an Auditor’s Eye”.

Trident to attend DIA 2011 in Chicago on 19 to 22 June

Karen West, BD Director will be in attendance, we welcome the opportunity for you to visit us at our Booth -No. 1217.  If you would like to set up a formal meeting please e-mail Karen kwest@tridentclinicalresearch.com

15 November 2010

Trident attends the BIO-Europe Partnering Conference

One of Australia's most respected CRO's, Trident Clinical Research, will be attending the BIO-Europe partnering conference, as part of the AusTrade delegations, in Munich from November 15-17.

Karen West, Director of Business Development for Trident, will be representing the company on what she believes will be an "enormously beneficial trip for us."

BIO-Europe is Europe's largest partnering conference, serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies.

According to Ms West, the BIO-Europe conference attracts leading dealmakers from biotechnology, pharmaceuticals, service companies and finance along with innovative emerging companies.
"BIO-Europe brings together CEOs, business development and licensing executives from biotech and pharma companies, contract research and manufacturing organizations," she said.

"Trident is undergoing significant growth at the moment, with offices in India, New Zealand and across Australia and we are finding that we are definitely on the radar in Europe as well.
This meeting will help us to raise our profile as the go-to CRO in the Asia-Pacific region for European companies even further."

About Trident Clinical Services: Trident Clinical Research is an independent, full service Contract Research Organisation, providing services to local and international clients across all clinical phases.
Trident specialises in providing reliable, timely services of the highest quality including feasibility assessments, protocol design, clinical monitoring, project management, data management, statistics, report writing and quality assurance consulting. All projects are conducted to ICH GCP and FDA requirements and our services are customised to suit each client's needs with teams dedicated to each trial.

With offices in Sydney, Brisbane, Melbourne, Adelaide, Auckland and Mumbai, Trident offers a CRO that is small enough to manage each project with individual care, as well as having the infrastructure to manage the largest trials from the initial stages to the final report - with speed, accuracy and reliability.

For further information please contact Tania Ewing on 0408378422

1 November 2010

Trident appoints new Chief Medical Officer

Former Genzyme executive David Fuller has been appointed to the position of Chief Medical Officer.

Dr Fuller's primary responsibility will be to manage the development of its suite of clinical trial services across a wide range of therapeutic conditions in both drugs and devices.

Managing Director Garth Tierney said Dr Fuller had an outstanding background in clinical development. "David brings a wealth of clinical and commercial experience to Trident and expands Trident's biotechnology expertise. As the company continues to expand its operations across Australia, New Zealand, India and eventually into Asia, David will be vital to the growth of our clinical trials in all areas".

Until April, Dr Fuller was chief medical officer of ASX listed Arana Therapeutics. Prior to his three years at Arana he was Vice-President, Clinical and Site General Manager at Genzyme Europe, based in the UK.

He has also held leadership roles at Orphan Medical and CeNeS and was responsible for successful clinical product progression, contributing to partnering activities, rapid expansion of the team and implementation of appropriate organisational structures.

Dr Fuller is qualified in medicine and pharmacy and has more than 20 years international experience in clinical development and commercialisation of new medicines.

Source: www.trialsinfocus.com

1 May 2009

Trident establishes a new office in Auckland New Zealand

Trident is pleased to announce that Trident Clinical Research NZ Limited has commenced operations from its new office in Auckland, New Zealand.

Trident NZ is a wholly owned subsidiary of the Australian parent company and will conduct operations under the management of Trident Australia.

The new Trident office will provide locally based resources for Trident's customers which will improve efficiencies in the conduct of trials in New Zealand.

The new office will support Trident's continued growth and commitment to clinical research in New Zealand and the Asia Pacific region.

8 February 2008

Trident announces establishment of New Zealand Operation

Trident is pleased to announce that Trident Clinical Research NZ Limited has commenced operations in New Zealand.

Trident NZ is a wholly owned subsidiary of the Australian parent company and will conduct operations under the management of Trident Australia.

he new Trident operation will provide locally based resources for Trident's customers which will improve efficiencies in the conduct of trials in New Zealand.

The operation will also facilitate local sponsorship for clinical trials.

July 2007

Trident Announces Opening of New Brisbane Office

Trident is pleased to anounce the opening of our new Brisbane office. The office located in Toowong about 15 minutes from the city and centralizes our Brisbane team.

Trident now has four main offices: Adelaide (Head Office), Sydney, Melbourne and Brisbane.

October 2006

Opening of Trident India

Trident is very pleased to announce the opening of Trident Clinical Research India Private Limited. Trident India completed registration requirements on the 12th September 2006 and is now operational in Mumbai.

Trident India provides a seemless extension to the Trident Australia services with shared infrastructure and procedures ensuring an efficient and high quality service. The Indian operation is headed by our Mangaging Director, Dr Samir Sadekar.

Samir is supported by an experienced team of research professionals suitable to handle the services in India.

India has recently been identified as one of the key growth countries by several large pharmaceutical and clinical research organisations. A large patient population, well trained and experienced investigators, well trained and English speaking study teams, good infrastructure and improved regulatory processes has provided an excellent environment for the growth of clinical research in India over the last few years.

This is likely to increase further and we are excited to be a part of the growth. This is also associated with significantly lower costs of running studies including service fees and study costs.

If you would like any further information, a brief presentation or would like to discuss clinical research in India, please do not hesitate to contact us.

May 2005

New Data Management Service

Trident is delighted to announce a new data management service will be operational from May 2005 and will be based in our new Melbourne offices. Trident has been fortunate to have one of Australia’s most experienced data management professionals, Peter Fursdon, join Trident to head the Data Management Department.

Peter has over 15 years' data management experience in the clinical research industry and has worked in Australia and the UK where he has headed data management departments in a number of CROs. Peter is joined by a team of experienced professionals to complete the data management team.

Our data management system is rigourously validated to meet FDA CFR 21 part 11 requirements and data management services include:

  • CRF design
  • Database management and database programming
  • Data entry, data monitoring and data cleaning
  • Medical coding (adverse events, medications and diseases)
  • Statistical sections of protocols and power calculations
  • Randomisation
  • SAS programming of tables, listings & graphs
  • Statistical analysis & reporting

April 2005

Trident Announces Opening of New Melbourne Office

The Trident team from around Australia came together on 31 March 2005 to celebrate the opening of our new Melbourne office.

The office located at 12 Cato Street, Hawthorn East, 3123 VIC is ideally situated in a brand new corporate building only 10 minutes from the city and 30 mins from the airport.

The new office provides a focal point for our growing Melbourne team and provides the infrastructure for large projects to be run from Melbourne. Trident now has three main offices: Adelaide (Head Office), Sydney and Melbourne.

May 2004

Trident Wins International Business Award

Adelaide-based Trident Clinical Research has been named 2004 Outstanding Incubator Business at a prestigious international event in the US.

The local company won the manufacturing/service category at the National Business Incubation Association's 18th International Conference on Business Incubation in Atlanta.

ENQUIRIES

Adelaide Office (Head Office)

Tel: +61-8-8447 3500

Fax: +61-8-8447 3511